Upload

Loading icon Loading...

This video is unavailable.

Modern Vaccine and Adjuvant Production and Characterization

Sign in to YouTube

Sign in with your Google Account (YouTube, Google+, Gmail, Orkut, Picasa, or Chrome) to like GENNews's video.

Sign in to YouTube

Sign in with your Google Account (YouTube, Google+, Gmail, Orkut, Picasa, or Chrome) to dislike GENNews's video.

Sign in to YouTube

Sign in with your Google Account (YouTube, Google+, Gmail, Orkut, Picasa, or Chrome) to add GENNews's video to your playlist.

Uploaded on Jan 10, 2012

Vaccine production technology has evolved from using agents produced in animal tissue, eggs, and cultures to the use of virus-like particles (VLP). Challenges remain, however, in the analysis of key parameters for all types of vaccines. Many VLP vaccines can be characterized using techniques used for other biological drugs, however, more complex VLP vaccines offer unique analytical challenges.

As both vaccines and adjuvant development and production technologies have evolved, so too have the methodologies used to meet more demanding manufacturing and regulatory standards. In this webinar you will learn about the use of multiple biophysical and biochemical approaches for candidate vaccine characterization and analytical characterization of vaccine adjuvant molecules and formulations, including the use of HPLC with charged aerosol detection.

Loading icon Loading...

Loading icon Loading...

Loading icon Loading...

The interactive transcript could not be loaded.

Loading icon Loading...

Loading icon Loading...

Ratings have been disabled for this video.
Rating is available when the video has been rented.
This feature is not available right now. Please try again later.

Loading icon Loading...

Loading...
Working...
to add this to Watch Later

Add to